...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Message: Imo this breakout is just starting

I agree.  

The chart people would point to a breakout just as the 50, 100 and 200 day moving averages were converging to $3.18, from which our share price took off.  While weekly averages indicated the move would happen a little later, $3 proved to be solid support. What I find most encouraging (like growacet), is the significantly higher volumes in the last 3 days.  

Next stop is $4.35 I think...the previous highs seen on September 2018.  News of a raise to pay off the loan would do it.  It would be most encouraging if this takes place on good volume.

Share
New Message
Please login to post a reply